Skip to main content

Advertisement

Log in

Auto-inflammation in a Patient with a Novel Homozygous OTULIN Mutation

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Damgaard RB, Walker JA, Marco-Casanova P, Morgan NV, Titheradge HL, Elliott PR, et al. The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity. Cell. 2016;166:1215–1230.e20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Zhou Q, Yu X, Demirkaya E, Deuitch N, Stone D, Tsai WL, et al. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc Natl Acad Sci U. S. A. 2016;113:10127–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Keusekotten K, Elliott PR, Glockner L, Fiil BK, Damgaard RB, Kulathu Y, et al. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell. 2013;153:1312–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Boisson B, Laplantine E, Prando C, Giliani S, Israelsson E, Xu Z, et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol. 2012;13:1178–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We kindly thank Saba Arshi, Mohammad Hassan Bemanian, Morteza Fallahpour, Alireza Nateghian, Farhad Abolhasan Chobdar, Davood Mansouri, Mehrnaz Mesdaghi, and Mojgan Kiani Amin for their cooperation and for their help in the work-up of the patient and taking care of the patient. We thank the patient and her family.

Research Funding

This work was supported by a Geconcerteerde Onderzoeksactie (GOA) grant from the Research Council of the Catholic University of Leuven, Belgium.

Author information

Authors and Affiliations

Authors

Contributions

Whole-exome sequencing, data analysis, and clinical diagnosis were done by Mohammad Shahrooei, Hassan Rokni-Zadeh, and Majid Changi-Ashtiani. Kian Darabi collected the data, Mostafa Manian gathered samples for analyses, and Farhad Seif made substantial contributions to design of the study and edited the draft. Mohammad Nabavi took care of the patient. Isabelle Meyts edited the draft. Jeroen Vrancken and Arnout Voet performed and described the modeling studies. Leen Moens and Xavier Bossuyt designed the experimental studies. Leen Moens performed the experimental analyses. Mohammad Nabavi and Xavier Bossuyt drafted the manuscript. All authors read and approved the manuscript.

Corresponding author

Correspondence to Xavier Bossuyt.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interests.

Ethical Approval

Informed consent was obtained.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

ESM 1

(DOCX 197 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nabavi, M., Shahrooei, M., Rokni-Zadeh, H. et al. Auto-inflammation in a Patient with a Novel Homozygous OTULIN Mutation. J Clin Immunol 39, 138–141 (2019). https://doi.org/10.1007/s10875-019-00599-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-019-00599-3

Navigation